Your browser doesn't support javascript.
loading
Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa, Michael; Arlt, Heike; He, Timothy; Ospina, Beatriz; Reeves, Jason; Zhang, Bailin; Murtie, Joshua; Deng, Gejing; Barberis, Claude; Hoffmann, Dietmar; Cheng, Hong; Pollard, Jack; Winter, Christopher; Richon, Victoria; Garcia-Escheverria, Carlos; Adrian, Francisco; Wiederschain, Dmitri; Srinivasan, Lakshmi.
Afiliación
  • Lampa M; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Arlt H; Oncology, Sanofi, Cambridge, MA, United States of America.
  • He T; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Ospina B; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Reeves J; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Zhang B; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Murtie J; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Deng G; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Barberis C; Integrated Drug Discovery Platform, Sanofi, Waltham, MA, United States of America.
  • Hoffmann D; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Cheng H; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Pollard J; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Winter C; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Richon V; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Garcia-Escheverria C; Research Platforms, Sanofi, Vitry-Sur-Seine, Vitry, FRANCE.
  • Adrian F; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Wiederschain D; Oncology, Sanofi, Cambridge, MA, United States of America.
  • Srinivasan L; Oncology, Sanofi, Cambridge, MA, United States of America.
PLoS One ; 12(9): e0185092, 2017.
Article en En | MEDLINE | ID: mdl-28950000

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Serina-Treonina Quinasas TOR / Neoplasias de la Mama Triple Negativas / Glutaminasa / Glutamina Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Serina-Treonina Quinasas TOR / Neoplasias de la Mama Triple Negativas / Glutaminasa / Glutamina Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos